Labiana Health

Labiana Health Days Payable Outstanding

The Days Payable Outstanding (DPO) of Labiana Health (LAB.MC) as of Nov 19, 2026 is 142.02. In the previous year, Days Payable Outstanding (DPO) was 126.43 — a change of 12.33% (higher).

Days Payable Outstanding

142.02

YoY

12.33%

Last updated:

Days Payable Outstanding (DPO) of Labiana Health is 2025 142.02 . Days Payable Outstanding (DPO) of Labiana Health was 2024 126.43 . It decreases by 12.33% higher compared to the previous year.

The Labiana Health Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2018
196.32 EUR
Jan 1, 2019
150.81 EUR
Jan 1, 2021
145.14 EUR
Jan 1, 2022
163.05 EUR
Jan 1, 2023
132.59 EUR
Jan 1, 2024
126.43 EUR
Jan 1, 2025
142.02 EUR
The Labiana Health Days Payable Outstanding history
YEARDays Payable OutstandingYoY
142.02+12.33%
126.43-4.65%
132.59-18.68%
163.05+12.34%
145.14-3.76%
150.81-23.18%
196.32—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Labiana Health Stock analysis

What does Labiana Health do? Labiana Health SA generates revenue through the development, manufacturing, and marketing of animal and human medicines. The company focuses on drug research and development, including galenic and analytical development, as well as drug manufacturing, which encompasses formulation development and bacterial vaccine manufacturing. Regulatory services for pharmaceutical product registration in global markets also contribute to its income. Its subsidiaries operate in Ecuador, Mexico, Serbia, and Turkey, serving markets for both animal and human pharmaceutical products. The company's primary products include sterile and lyophilized dosage forms, which are manufactured for use in animal and human medicine. These products are sold to customers in the pharmaceutical industry, including distributors and healthcare providers in the regions where Labiana Health SA has a presence. The company’s R&D and manufacturing capabilities support the production of medicines that meet regulatory standards for global markets. Labiana Health SA’s business model relies on its subsidiaries in Ecuador, Mexico, Serbia, and Turkey to facilitate market access and distribution. The company’s revenue streams are derived from the sale of pharmaceutical products, regulatory services, and the development of new drug formulations. Its focus on sterile and lyophilized dosage forms positions it within the specialized pharmaceutical manufacturing sector, targeting both animal and human medicine segments. Labiana Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Labiana Health stock

Days Payable Outstanding (DPO) of Labiana Health is 142.02 in 2025.

Days Payable Outstanding (DPO) of Labiana Health changed from 126.43 to 142.02, representing a 12.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) Labiana Health since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s Labiana Health with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Labiana Health

All Key Metrics — Labiana Health